a1 Psychopharmacology Research Branch, National Institute of Mental Health, Maryland, USA
Three hundred and sixty depressed in-patients initialy treated with imipramine, chlorpromazine or a placebo were re-evaluated a year later. Patients showing the poorest adjustment at one year were those who failed to show a good initial response to treatment and those who responded positively to a placebo.
c1 Address for correspondence: Dr Allen Raskin, Psycho-pharmacology Research Branch, National Institute of Mental Health, 5600 Fishers Lane, Room 9–101, Rockville, Maryland 20857, USA.
p1 Present address: Center for Studies of Child and Family Mental Health, National Institute of Mental Health.